Carbonic anhydrase inhibitors. Inhibition of the membrane-bound human and bovine isozymes IV with sulfonamides

Bioorganic and Medicinal Chemistry Letters

Volumn 15, Issue 4, 2005, Pages 1149-1154

  Innocenti, Alessio ^a   Firnges, Michael A ^b   Antel, Jochen ^b   Wurl, Michael ^b   Scozzafava, Andrea ^a   Supuran, Claudiu T ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Solvay Pharmaceuticals GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; BROMOSULFANILAMIDE; CARBONATE DEHYDRATASE I; CARBONATE DEHYDRATASE II; CARBONATE DEHYDRATASE INHIBITOR; CARBONATE DEHYDRATASE IV; CELECOXIB; DICLOFENAMIDE; DORZOLAMIDE; ETHOXZOLAMIDE; METHAZOLAMIDE; SULFANILAMIDE DERIVATIVE; SULFONAMIDE; TOPIRAMATE; UNCLASSIFIED DRUG; VALDECOXIB;

ARTICLE; COW; DRUG EFFECT; DRUG POTENCY; ENZYME INHIBITION; INTRAOCULAR PRESSURE; SPECIES DIFFERENCE;

BOVINAE;

EID: 16244381734     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2004.12.009     Document Type: Article

References (39)

1. C.T. Supuran A. Scozzafava J. Conway Carbonic Anhydrase-Its Inhibitors and Activators 2004 CRC Boca Raton (FL), USA 1 376 and references cited therein
2. S. Pastorekova, S. Parkkila, J. Pastorek, and C.T. Supuran J. Enzyme Inhib. Med. Chem. 19 2004 199 229
3. C.T. Supuran, D. Vullo, G. Manole, A. Casini, and A. Scozzafava Curr. Med. Chem.-Cardiovasc. Hematol. Agents 2 2004 49 68
4. C.T. Supuran, A. Scozzafava, and A. Casini Med. Res. Rev. 23 2003 146 189
5. C.T. Supuran, and A. Scozzafava Expert Opin. Ther. Patent 12 2002 217 242
6. C.T. Supuran Carbonic Anhydrases: Catalytic Mechanism, Distribution and Physiological Roles C.T. Supuran A. Scozzafava J. Conway Carbonic Anhydrase-Its Inhibitors and Activators 2004 CRC Boca Raton (FL), USA 1 24
7. A. Scozzafava, A. Mastrolorenzo, and C.T. Supuran Expert Opin. Ther. Pat. 14 2004 667 702
8. A. Weber, A. Casini, A. Heine, D. Kuhn, C.T. Supuran, A. Scozzafava, and G. Klebe J. Med. Chem. 47 2004 550 557
9. P.L. Whitney, and T.V. Briggle J. Biol. Chem. 257 1982 12056 12059
10. W.S. Sly, and P.Y. Hu Annu. Rev. Biochem. 64 1995 375 401
11. X.L. Zhu, and W.S. Sly J. Biol. Chem. 265 1990 8795 8801
12. T.T. Baird Jr., A. Waheed, T. Okuyama, W.S. Sly, and C.A. Fierke Biochemistry 36 1997 2669 2678
13. T. Stams, S.K. Nair, T. Okuyama, A. Waheed, W.S. Sly, and D.W. Christianson Proc. Natl. Acad. Sci. U.S.A. 93 1996 13589 13594
14. T. Stams, Y. Chen, P.A. Boriack-Sjodin, J.D. Hurt, J. Liao, J.A. May, T. Dean, P. Laipis, D.N. Silverman, and D.W. Christianson Protein Sci. 7 1998 556 563
15. C.Y. Kim, D.A. Whittington, J.S. Chang, J. Liao, J.A. May, and D.W. Christianson J. Med. Chem. 45 2002 888 893
16. T.H. Maren, G.C. Wynns, and P.J. Wistrand Mol. Pharmacol. 44 1993 901 906
17. C.T. Supuran, M.A. Ilies, and A. Scozzafava Eur. J. Med. Chem. 33 1998 739 751
18. C.T. Supuran, and A. Scozzafava J. Enzyme Inhib. 12 1997 37 51
19. A. Scozzafava, and C.T. Supuran J. Enzyme Inhib. 13 1998 419 442
20. C.T. Supuran, F. Briganti, and A. Scozzafava J. Enzyme Inhib. 12 1997 175 190
21. F. Mincione, L. Menabuoni, F. Briganti, G. Mincione, A. Scozzafava, and C.T. Supuran J. Enzyme Inhib. 13 1998 267 284
22. C.T. Supuran, A. Scozzafava, M.A. Ilies, B. Iorga, T. Cristea, F. Briganti, F. Chiraleu, and M.D. Banciu Eur. J. Med. Chem. 33 1998 577 595
23. A. Scozzafava, L. Menabuoni, F. Mincione, F. Briganti, G. Mincione, and C.T. Supuran J. Med. Chem. 42 1999 2641 2650
24. A. Scozzafava, F. Briganti, G. Mincione, L. Menabuoni, F. Mincione, and C.T. Supuran J. Med. Chem. 42 1999 3690 3700
25. A. Scozzafava, L. Menabuoni, F. Mincione, F. Briganti, G. Mincione, and C.T. Supuran J. Med. Chem. 43 2000 4542 4551
26. A. Casini, A. Scozzafava, F. Mincione, L. Menabuoni, M. Starnotti, and C.T. Supuran Bioorg. Med. Chem. Lett. 13 2003 2867 2873
27. A. Scozzafava, L. Menabuoni, F. Mincione, and C.T. Supuran J. Med. Chem. 45 2002 1466 1476
28. A. Casini, J. Antel, F. Abbate, A. Scozzafava, S. David, H. Waldeck, S. Schäfer, and C.T. Supuran Bioorg. Med. Chem. Lett. 13 2003 841 845
29. 12
30. G. Behravan, B.H. Jonsson, and S. Lindskog Eur. J. Biochem. 190 1990 351 357
31. R.G. Khalifah, D.J. Strader, S.H. Bryant, and S.M. Gibson Biochemistry 16 1977 2241 2247
32. S. Lindskog, and J.E. Coleman Proc. Natl. Acad. Sci. U.S.A. 70 1964 2505 2508
33. H. Steiner, B.H. Jonsson, and S. Lindskog Eur. J. Biochem. 59 1975 253 259
34. 4, 300 mM NaCl, 10 mM imidazole, pH 8.0) per gram of cells containing 200 μg/mL lysozyme. The suspension was incubated on ice for 30 min and treated with a sonicator (six times for 10 s with 10 s cooling time in between). After centrifugation at 10,000g for 30 min at 4°C the cleared lysate was incubated with Ni-NTA suspension (Qiagen). The expressed protein was purified according to the manufacturer's protocol. The isolated hCA IV was further purified by Sephadex G25 chromatography (Amersham). The purified enzyme had a catalytic activity very similar to that described in Ref. 8
35. 2 solutions in water at 20°C were used as substrate. Stock solutions of inhibitors were prepared at a concentration of 10-50 mM (in the assay buffer) and dilutions up to 0.01 nM done with the assay buffer mentioned above. Enzyme concentrations were 0.09 μM for hCA I, 0.06 μM for hCA II, 1 μM for hCA IV and bCA IV. Inhibition constants were calculated as described by R.G. Khalifah J. Biol. Chem. 246 1971 2561 2573
36. F. Mincione, L. Menabuoni, and C.T. Supuran Clinical Applications of Carbonic Anhydrase Inhibitors in Ophthalmology V.T. Supuran A. Scozzafava J. Conway Carbonic Anhydrase: Its Inhibitors and Activators 2004 CRC Boca Raton, FL 243 254
37. M.F. Sugrue Prog. Retinal Eye Res. 19 2000 87 112
38. S.Y. Liao, S. Ivanov, A. Ivanova, S. Ghosh, M.A. Cote, K. Keefe, M. Coca-Prados, E.J. Stanbridge, and M.I. Lerman J. Med. Genet. 40 2003 257 261
39. B. Alvarez, F.B. Loiselle, C.T. Supuran, G.J. Schwartz, and J.R. Casey Biochemistry 42 2003 12321 12329